[Federal Register Volume 69, Number 47 (Wednesday, March 10, 2004)]
[Notices]
[Page 11448]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-5504]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of Meeting
The Office of the Director, National Institutes of Health (NIH),
announces a meeting of the NIH Blue Ribbon Panel on Conflict of
Interest Policies, a working group of the Advisory Committee to the
director, NIH. The meeting is scheduled for March 12-13, 2004. The
meeting will be held at the NIH, 9000 Rockville Pike, Bethesda,
Maryland, Building 31C, Conference Room 6. Attendance will be limited
to space available. In the interest of security, NIH has instituted
stringent procedures for entrance into the building by non-government
employees. Persons without a government I.D. will need to shop a photo
I.D. and sign in at the security desk upon entering the building.
On March 12, the Panel will meet in closed, Executive Session, from
8:30-10 a.m., and in public session, from 10 a.m.-6:15 p.m. On March
13, the Panel will meet in closed, Executive Session, from 8:30 a.m.-2
p.m. The agenda will be posted on the NIH Web site (http://www.nih.gov)
prior to the meeting.
During the public session, time will be set aside for oral
presentations by the public. Any person wishing to take a presentation
should notify Charlene French, Office of Science Policy, National
Institutes of Health, Building 1, Room 103, Bethesda, Maryland 20892,
telephone (301) 496-2122 by March 11, 2004 or by e-mail:
[email protected].
Oral comments will be limited to 5 minutes. Due to time
constraints, only one representative from each organization will be
allotted time for oral testimony. The number of speakers and the time
allotment may also be limited by the number of presentations. The
opportunity to speak will be based on a first come first served basis.
All requests to present oral comments should include the name,
addresses, telephone number, and business or professional affiliation
of the interested party, and should indicate the areas of interest or
issue to be addressed. Please provide, if possible, an electronic copy
of your comments.
Any person attending the meeting who has not registered to speak in
advance of the meeting will be allowed to make a brief oral statement
during the time set aside for public comment, if time permits and at
the discretion of the co-chairs.
Individuals who plan to attend the meeting and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify Charlene French at the address listed
earlier in this notice in advance of the meeting.
Dated: March 5, 2004.
LaVerne Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-5504 Filed 3-8-04; 8:45 am]
BILLING CODE 4140-01-M